3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
35
Neoplasms
23
Motor Activity
11
Stomach Neoplasms
7
Pain, Postoperative
7
Lung Neoplasms
7
Fatigue
7
Colorectal Neoplasms
7
Pain
5
Anxiety Disorders
5
Polycystic Ovary Syndrome
4
Depression
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Stomatitis
3
Sleep Initiation and Maintenance Disorders
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Malnutrition
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Colonic Neoplasms
3
Agnosia
3
Vomiting
2
Urinary Incontinence
2
Squamous Cell Carcinoma of Head and Neck
2
Parasomnias
2
Ovarian Neoplasms
2
Interventions
HMPL-013
1
Drug Therapy
1
Control Groups
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Unresectable Metastatic Colorectal Cancer
×
Control Groups
×
Clear all
NCT06642844
2024-10-15
PHARBEVACOL
University Hospital, Tours
Phase 3
Not yet recruiting
244 enrolled